Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 08 2021
Historique:
received: 14 03 2019
accepted: 26 05 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 9 11 2021
Statut: epublish

Résumé

We test the hypothesis that endothelial cells adopt an inflammatory phenotype in functionally intact aged human subjects with radiographic evidence of white matter hyperintensity (WMH) suggestive of small cerebrovascular disease. Components of all three complement effector pathways and regulatory proteins were quantified in extracts of plasma endothelial-derived exosomes (EDE) of 11 subjects (age 70-82) with and 15 without evidence of WMH on MRI. Group differences and associations with plasma markers of immune activation (IL6, ICAM1), cognition and neuroimaging were calculated via regression modelling. EDE complement factors within the alternative and classical pathways were found to be higher and regulatory proteins lower in subjects with WMH. EDE levels of some complement components demonstrated significant associations with cognitive slowing and elevated systolic blood pressure. The inhibitor of the membrane attack complex, CD46, showed a significant positive association with cerebral grey matter volume. Plasma inflammatory markers, IL6 and ICAM1, were positively associated with EDE levels of several complement components. These findings provide the first in vivo evidence of the association of endothelial cell inflammation with white matter disease, age-associated cognitive changes, and brain degeneration in functionally normal older individuals. Future endothelial biomarker development may permit recognition of early or preclinical stages of vascular contributions to cognitive impairment and dementia.

Identifiants

pubmed: 34376699
doi: 10.1038/s41598-021-91759-2
pii: 10.1038/s41598-021-91759-2
pmc: PMC8355229
doi:

Substances chimiques

Biomarkers 0
Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

16198

Subventions

Organisme : CSRD VA
ID : IK2 CX002180
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG019724
Pays : United States
Organisme : NINDS NIH HHS
ID : UH3 NS100608
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG061253
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Nat Immunol. 2018 Nov;19(11):1212-1223
pubmed: 30323343
FASEB J. 2016 Dec;30(12):4141-4148
pubmed: 27601437
J Neurol. 2017 Jul;264(7):1474-1481
pubmed: 28653212
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Nature. 2011 Jul 13;475(7355):S8
pubmed: 21760582
Mol Immunol. 2011 Aug;48(14):1592-603
pubmed: 21546088
JAMA. 2017 Apr 11;317(14):1443-1450
pubmed: 28399252
Annu Rev Cell Dev Biol. 2007;23:519-47
pubmed: 17506697
Neurology. 2017 Jan 31;88(5):426-432
pubmed: 28031395
Front Aging Neurosci. 2018 Nov 09;10:343
pubmed: 30483114
Cell Mol Bioeng. 2016 Dec;9(4):509-529
pubmed: 28392840
Alzheimers Dement. 2015 Jun;11(6):600-7.e1
pubmed: 25130657
Stroke. 2011 Jul;42(7):1917-22
pubmed: 21636811
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):466-471
pubmed: 29100854
Neuroimage Clin. 2017 Sep 14;16:595-603
pubmed: 28975068
Front Cell Neurosci. 2015 Feb 02;9:28
pubmed: 25698933
Nat Commun. 2015 Sep 10;6:8164
pubmed: 26353940
Neurology. 2012 Jul 31;79(5):442-8
pubmed: 22815562
Nat Neurosci. 2019 Mar;22(3):421-435
pubmed: 30664769
Ann Neurol. 2018 Mar;83(3):544-552
pubmed: 29406582
J Biol Chem. 2018 May 11;293(19):7195-7208
pubmed: 29555686
Neuron. 2019 Mar 20;101(6):1099-1108.e6
pubmed: 30737131
J Exp Med. 2018 Sep 3;215(9):2235-2245
pubmed: 30082275
Lancet. 2004 Apr 3;363(9415):1139-46
pubmed: 15064035
Neurobiol Aging. 2005 Apr;26(4):491-510
pubmed: 15653178
N Engl J Med. 2010 Jan 28;362(4):329-44
pubmed: 20107219
FASEB J. 2017 Aug;31(8):3689-3694
pubmed: 28476896
Cell Res. 2017 Jul;27(7):849-850
pubmed: 28674430
Dement Geriatr Cogn Disord. 2017;44(5-6):343-353
pubmed: 29421784
Neurology. 2015 Jul 7;85(1):40-7
pubmed: 26062630
J Pathol Transl Med. 2018 Jan;52(1):1-8
pubmed: 29370511
Alzheimers Dement. 2019 Jan;15(1):158-167
pubmed: 30642436
Cogn Behav Neurol. 2003 Dec;16(4):211-8
pubmed: 14665820
Front Neurosci. 2017 May 22;11:278
pubmed: 28588440
Stroke. 2005 Jan;36(1):50-5
pubmed: 15576652
Circ Res. 2017 Jul 21;121(3):258-269
pubmed: 28515043
Nature. 2011 Jul 13;475(7355):S9-11
pubmed: 21760583
Ann Clin Transl Neurol. 2015 Jul;2(7):769-73
pubmed: 26273689
Front Neurol. 2018 Apr 06;9:221
pubmed: 29681883
J Neurophysiol. 2016 Nov 1;116(5):2093-2104
pubmed: 27512019
Biochim Biophys Acta. 2016 Mar;1862(3):403-10
pubmed: 26432482

Auteurs

Fanny M Elahi (FM)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. elahilab15@gmail.com.

Danielle Harvey (D)

Department of Public Health Sciences, University of California, Davis, Davis, CA, USA.

Marie Altendahl (M)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Nivetha Brathaban (N)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Nicole Fernandes (N)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Kaitlin B Casaletto (KB)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Adam M Staffaroni (AM)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Pauline Maillard (P)

Department of Neurology and Center for Neuroscience, University of California, Davis, Davis, CA, USA.

Jason D Hinman (JD)

Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA.

Bruce L Miller (BL)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Charles DeCarli (C)

Department of Neurology and Center for Neuroscience, University of California, Davis, Davis, CA, USA.

Joel H Kramer (JH)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Edward J Goetzl (EJ)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. edward.goetzl@ucsf.edu.
Jewish Home of San Francisco, San Francisco, CA, USA. edward.goetzl@ucsf.edu.
Geriatric Research Center, 1719 Broderick St., San Francisco, CA, USA. edward.goetzl@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH